Business Context and Reporting Period
This Form 8-K was filed by AXA Equitable Holdings, Inc. on March 28, 2019. The report addresses a material event occurring on March 28, 2019, following a secondary public offering of the Company's common stock completed by AXA S.A. on March 25, 2019.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance and legal agreement event rather than financial performance metrics.
Material Changes
- Change in Control: Following the March 25, 2019 secondary offering, AXA S.A. no longer directly or indirectly owns or controls more than 50% of the Company's voting capital stock.
- Termination of Agreement: On March 28, 2019, AXA exercised its right to terminate the Trademark License Agreement dated May 4, 2018, due to the Change in Control.
- Trademark Usage: The Company retains the right to use certain "Licensed Marks" (including the name "AXA" and specific domain names) for a transition period of 18 months. This period may be extended, capped at a total of 36 months, provided the Company uses reasonable best efforts to transition to other trademarks.
Outlook, Risks, and Management Commentary
The primary risk identified is the loss of the right to use the "AXA" brand name and associated domain names in the Company's retirement and protection business in the United States and Canada after the transition period expires. Management is required to use reasonable best efforts to transition to alternative trademarks during the 18-to-36-month window. No financial guidance or other management commentary regarding future earnings is provided in this filing.
Key Facts for Investor Verification
- Confirm the exact expiration date of the 18-month transition period for trademark usage.
- Verify the Company's strategy and progress regarding the transition to new trademarks.
- Assess the potential impact of rebranding on the Company's retirement and protection business lines in the U.S. and Canada.
- Review the terms of the Trademark License Agreement to understand any specific limitations on the transition period extension.